Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases

Each year schistosomiasis afflicts up to 600 million people in 74 tropical and sub-tropical countries, predominantly in the developing world. Yet we depend on a single drug, praziquantel, for its treatment and control. There is no vaccine available but one is urgently needed especially since praziqu...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ridi, Rashika, Tallima, Hatem, Dalton, John P., Donnelly, Sheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021144/
https://www.ncbi.nlm.nih.gov/pubmed/24847355
http://dx.doi.org/10.3389/fgene.2014.00119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021144/
https://www.ncbi.nlm.nih.gov/pubmed/24847355
http://dx.doi.org/10.3389/fgene.2014.00119

Ejemplares similares